Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the efficacy, safety and tolerability of indisulam (I) in combination with capecitabine (C) versus capecitabine (C) monotherapy in patients with metastatic breast cancer following prior anthracycline and taxane therapy. The primary objective is to demonstrate superior time to progression with the IC combination regimen.
Critère d'inclusion
- Treatment of metastatic breast cancer